Posts by: Patricia Silva PhD

Patricia Silva PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

August 24, 2015August 24, 2015

Review On The Link Between Autophagy And ALS

News

Researchers at Università degli Studi di Milano in Italy recently published in the journal Cells a review regarding the link between autophagy and amyotrophic lateral sclerosis (ALS). The study is ... Read more

August 21, 2015August 21, 2015

Antibodies Against Key ALS Protein Reveal New Disease Insights

News

Researchers at the University of Toronto and the Sunnybrook Health Sciences Centre in Canada recently reported the development of two new antibodies against a protein that plays a key role ... Read more

August 20, 2015August 20, 2015

Researchers Develop Novel Model To Study Motor Neuron Diseases, Including ALS

News

Researchers at Ulm University and Eberhard Karls University in Germany recently developed a new in vitro model for the study of motor neuron diseases including amyotrophic lateral sclerosis (ALS). The ... Read more

August 13, 2015August 13, 2015

Study Reveals New Insights Into SOD1 Mutations and ALS

News

A study led by researchers at the National Institute of Neurological Disorders and Stroke (NINDS) recently published in the journal Neuron revealed new insights into why mutations in the SOD1 ... Read more

August 10, 2015August 10, 2015

New Fly Model To Study Motor Neuron Degeneration, ALS

News

Researchers at the University of Massachusetts Medical School in the United States and the Babraham Institute in the United Kingdom recently revealed a new fly model to study motor neuron ... Read more

July 30, 2015July 30, 2015

Results on Ibudilast Clinical Trial To Be Presented At 2015 International Symposium on ALS/MND

News

MediciNova, Inc., a biopharmaceutical company established in San Diego, recently announced in a press release that an abstract centered on the ongoing clinical trial evaluating the company’s product MN-166 (ibudilast) ... Read more

July 16, 2015July 16, 2015

Antioxidant MitoQ Shown As A Promising Therapy for ALS

amyotrophic lateral sclerosis (ALS), News

A study led by researchers at The Center of Free Radical and Biomedical Research at Universidad de la Republica in Uruguay revealed that antioxidant therapies like MitoQ are a promising ... Read more

July 10, 2015July 10, 2015

New Potential Biomarker and Therapeutic Target for ALS Patients

News

New data revealing a link between the LDL receptor-related protein 4 (LRP4) and amyotrophic lateral sclerosis (ALS) was presented during the 67th American Academy of Neurology Annual Meeting in April 2015. ... Read more

July 9, 2015July 9, 2015

Misfolded Protein Aggregates in Neurodegenerative Diseases

News

Researchers at the University of Alberta and the National Institute for Nanotechnology in Canada recently reported new insights into the misfolding process of proteins from a normal structure to a ... Read more

July 7, 2015July 7, 2015

Researchers Discover Eight Master Regulators of Neurodegeneration in ALS Animal Models

News

Researchers at Columbia University, New York recently published in the journal Cell Reports their findings on eight different master regulators involved in amyotrophic lateral sclerosis (ALS) neurodegeneration in mouse models. ... Read more

Pin It on Pinterest